The FDA Outlook of Events Reporting after Ticagrelor or...

The FDA Outlook of Events Reporting after Ticagrelor or Clopidogrel in the PLATO Trial: Impact of Sponsor Censoring Dates, Drug Discontinuation, and Withdrawal of Consent

Serebruany, Victor L.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
120
Year:
2011
Language:
english
Journal:
Cardiology
DOI:
10.1159/000335476
File:
PDF, 106 KB
english, 2011
Conversion to is in progress
Conversion to is failed